Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
In Vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model
Methods in Molecular Biology, Volume 1030, Year 2013
Notification
URL copied to clipboard!
Description
Several animal models with varying susceptibilities to respiratory syncytial virus (RSV) infection have been developed to study the specific aspects of RSV disease. Many of these models are used for testing antiviral compounds or in vaccine efficacy studies during preclinical evaluation. In this chapter, we describe the study design of an efficacy study of an RSV inhibitor, performed in a juvenile vervet monkey model for RSV. © 2013 Springer Science+Business Media, LLC.
Authors & Co-Authors
Houspie, Lieselot
Belgium, Leuven
Ku Leuven
Ngotho, Maina
Kenya, Nairobi
National Museums of Kenya
Keyaerts, Els
Belgium, Leuven
Ku Leuven
van Ranst, Marc A.
Belgium, Leuven
Ku Leuven
Maes, Piet
Belgium, Leuven
Ku Leuven
Statistics
Authors: 5
Affiliations: 2
Identifiers
Doi:
10.1007/978-1-62703-484-5_29
ISSN:
10643745